NCT05133947

Pre-study to Evaluate IENFD Induction in Patients With Taxane-induced CIPN

A Clinical Study Examining Intraepidermal Nerve Fiber Density (IENFD) in Patients With Chemotherapy-induced Peripheral Neuropathy (CIPN) Compared With Healthy Subjects

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 24 (actual)
• Sponsor: Beijing 3E-Regenacy Pharmaceuticals Co., Ltd. · Industry
• Sex: Female
• Age: 18 Years – 70 Years
• Healthy volunteers: Accepted

Summary

This is a non-interventional study examining IENFD levels in patients with CIPN after taxane chemotherapy and in age-matched healthy subjects.

Detailed description

This is a non-interventional study examining IENFD levels in patients with CIPN after taxane chemotherapy and in age-matched healthy subjects. After the subjects sign the informed consent, the study physicians will judge the inclusion and exclusion criteria. Subjects meeting the inclusion requirements will register at the study center according to the requirements of the study physicians, and skin samples will be collected by specialized researchers.

Conditions

• Peripheral Nervous System Diseases

Interventions

Type	Name	Description
OTHER	Non interventional	Non interventional

Timeline

• Start date: 2021-10-12
• Primary completion: 2022-03-01
• Completion: 2022-06-30
• First posted: 2021-11-24
• Last updated: 2023-04-03

Locations

1 site across 1 country: China